Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
25m
Zydus Lifesciences gets in-principle approval from WHO for ZyVac TCV, shares up 2%
ZyVac TCV is designed for active immunization against Salmonella typhi infection in individuals aged 6 months to 65 years.
The Financial Express
23m
WHO prequalifies Zydus’s Typhoid vaccine
As per GAVI (2022) it is estimated that Typhoid accounts for an estimated 11 to 21 million cases of febrile illness and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Linked to E. coli outbreak
To appear on Rogan podcast
Arrested in trafficking case
Target to cut prices
To headline 2 Harris rallies
SK mulls arms for Ukraine
Veteran film producer dies
Ordered to hand over assets
Reveals 2025 tax brackets
Trespassing charge upheld
Giant ‘ghost’ fish spotted
2025 Medicare changes
Six indicted for fraud in Ohio
Infant mortality increased
Probing leak of US intel
US semiconductor tax credit
FAA finalizes safety rules
Right whale population rises
FTC bans fake reviews
PA political threat case
Brain stimulation study
Same-day pharmacy delivery
Hospitals' IV fluid shortage
MO court upholds release
Lake Erie toxic algae study
2 US troops injured in raid
Tests facial recognition tech
DOJ alleges racial bias
Raises US growth forecast
Feedback